IGM Biosciences IGMS - 옵션 체인 | ADVFN

다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

IGM Biosciences Inc (IGMS)

1.295

-0.095

( -6.83% )

업데이트: 04:27:39

IGMS 실시간 옵션 플로우

콜

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
2.50	0.03	0.05	0.03	0.04	0.00	0.00 %	0	305	-
5.00	0.05	0.05	0.05	0.05	0.00	0.00 %	0	104	-
7.50	0.15	0.50	0.15	0.325	0.00	0.00 %	0	47	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.05	0.50	0.05	0.275	0.00	0.00 %	0	126	-
17.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
22.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
25.00	0.00	0.50	0.00	0.00	0.00	0.00 %	0	0	-

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

풋

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
2.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
7.50	6.10	6.30	0.00	6.20	0.00	0.00 %	0	0	-
10.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
12.50	11.10	11.80	10.80	11.45	0.00	0.00 %	0	0	-
15.00	13.60	13.80	3.60	13.70	0.00	0.00 %	0	0	-
17.50	16.10	16.80	5.20	16.45	0.00	0.00 %	0	0	-
20.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
22.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
25.00	23.50	25.40	13.50	24.45	0.00	0.00 %	0	0	-

가장 활성
% 상승자
% 패자

기호	가격	볼륨
RGCRegencell Bioscience Holdings Ltd	US$ 12.92 (207.62%)	19.36M
HMRHeidmar Maritime Holdings Corporation	US$ 4.175 (63.73%)	80.75M
LZMHLZ Technology Holdings Ltd	US$ 13.05 (59.54%)	685.58k
ICONIcon Energy Corporation	US$ 0.1305 (40.17%)	54.94M
AVAHAveanna Healthcare Holdings Inc	US$ 5.18 (38.50%)	3.03M
CMCTCreative Media and Community Trust Corporation	US$ 0.35 (-46.15%)	1.75M
ADTXAditxt Inc	US$ 0.03375 (-40.58%)	109.53M
SPHLSpringview Holdings Ltd	US$ 0.7385 (-40.44%)	2.12M
ULYUrgent ly Inc	US$ 0.31 (-39.17%)	1.71M
AREBAmerican Rebel Holdings Inc	US$ 0.2185 (-33.28%)	3.77M
SPGCSacks Parente Golf Inc	US$ 0.1339 (23.98%)	357.22M
NVDANVIDIA Corporation	US$ 116.195 (0.39%)	249.97M
INTCIntel Corporation	US$ 23.6677 (14.45%)	215.39M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 8.5588 (-6.36%)	204.78M
TQQQProShares UltraPro QQQ	US$ 57.97 (-5.17%)	110.21M

Monksdream

Monksdream 8 월 전

Monksdream

Monksdream 10 월 전

crudeoil24

crudeoil24 3 년 전

Truist Reiterates Buy Rating, $80 Price Target.

crudeoil24

crudeoil24 3 년 전

Let's see if IGMS gets FDA phase I,II,III, approvals . Sanofi believes it'll happen.

crudeoil24

crudeoil24 3 년 전

crudeoil24

crudeoil24 3 년 전

Tons of cash going forward > IGM Biosciences, Inc. (NASDAQ: IGMS) today announced that it intends to offer and sell $200.0 million of shares of its common stock and, in lieu of common stock to certain investors that so choose, non-voting common stock, in an underwritten public offering. In addition, IGM intends to grant the underwriters a 30-day option to purchase up to an additional $30.0 million of shares at the public offering price, less underwriting discounts and commissions. All of the securities offered in the offering will be sold by IGM. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
J.P. Morgan, BofA Securities, Stifel, and Guggenheim Securities are acting as joint book-running managers for the offering.

TheFinalCD

TheFinalCD 3 년 전

https://ih.advfn.com/stock-market/NASDAQ/igm-biosciences-IGMS/stock-news/87682546/igm-announces-proposed-public-offering

https://www.wsgr.com/print/v2/content/185066/Firm-Advises-IGM-Biosciences%2C-Inc.-on-%24230-Million-Public-Offering.pdf

IGM Biosciences

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관